Study to Assess How Different Oral Formulations of Ubrogepant Move Through the Body in Healthy Adult Participants

StatusActive, Not Recruiting
PhasePhase 1
SponsorAbbVie
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints: details revised at 3 of 10 entries
    • Enrollment closed, study ongoing
    • Site details revised
    • Eligibility criteria expanded, about 4 words
  2. Recruitment opened
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 30, 2026 to Jul 14, 2026
    v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
AbbVie
349 trials monitored
See 27 trials at risk
This study will assess how different oral formulations of ubrogepant move through the body in healthy adult participants under fasting and fed conditions.
Trial Details
NCT Number NCT07680686
Lead Sponsor AbbVie
Conditions
(from sponsor)		 Healthy Volunteer
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov